# FDA 483 - Institute of Regenerative and Cellular Medicine - October 19, 2021

Source: https://www.globalkeysolutions.net/records/483/institute-of-regenerative-and-cellular-medicine/c4e8fd7d-1331-44d7-868f-c7b3555b32dd

> FDA 483 for Institute of Regenerative and Cellular Medicine on October 19, 2021. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Institute of Regenerative and Cellular Medicine
- Inspection Date: 2021-10-19
- Product Type: biologics
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/institute-of-regenerative-and-cellular-medicine/bc49599c-bed8-4ff7-837d-4ef60b18135d)
- [483 - 2021-10-19](https://www.globalkeysolutions.net/records/483/institute-of-regenerative-and-cellular-medicine/6812f0fd-d2a4-4581-890a-2a569d34fbe1)
- [483 - 2021-10-19](https://www.globalkeysolutions.net/records/483/institute-of-regenerative-and-cellular-medicine/380893af-ae02-42ac-9237-6ee1909eb0d0)
- [483 - 2021-10-19](https://www.globalkeysolutions.net/records/483/institute-of-regenerative-and-cellular-medicine/89e533f2-e930-489c-855b-16bf5684d476)

## Related Officers

- [Director of Compliance Branch](https://www.globalkeysolutions.net/people/ronda-loyd-jones/1446ba41-f1f2-4d40-8902-021b2bef3a53)
- [Christina D. Mello](https://www.globalkeysolutions.net/people/christina-d-mello/b523622e-d2dd-4ff6-9b2b-74b3134841de)

Company: https://www.globalkeysolutions.net/companies/institute-of-regenerative-and-cellular-medicine/09a4f8e2-c062-4f0b-8e9a-54de69b7d6bf

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6
